Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Next >>

Date	Time	Source	Headline	Symbol	Company
06/07/2021	11:30AM	PR Newswire (US)	CAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Chemotherapy-Free Combination Has ...	NYSE:ABBV	AbbVie Inc
06/07/2021	7:01AM	PR Newswire (Canada)	AbbVie reçoit l'approbation de Santé Canada pour l'emploi de RINVOQ® (upadacitinib) dans le traitement des adultes atteint...	NYSE:ABBV	AbbVie Inc
06/07/2021	7:01AM	PR Newswire (Canada)	Health Canada Approves AbbVie's RINVOQ® (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis	NYSE:ABBV	AbbVie Inc
06/04/2021	9:00AM	PR Newswire (US)	Results from IMBRUVICA® (ibrutinib) RESONATE-2 Study Provide Up to Seven Years of Progression-Free and Overall Survival Data...	NYSE:ABBV	AbbVie Inc
06/02/2021	8:30AM	PR Newswire (US)	AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference	NYSE:ABBV	AbbVie Inc
06/02/2021	8:00AM	PR Newswire (US)	Phase 3 Maintenance Results Show Patients with Crohn's Disease Receiving Risankizumab (SKYRIZI®) Achieved Endoscopic Respons...	NYSE:ABBV	AbbVie Inc
06/02/2021	7:30AM	PR Newswire (US)	AbbVie to Present Analysis Evaluating Continuous RINVOQ® (upadacitinib) Treatment in Psoriatic Arthritis for More Than One Y...	NYSE:ABBV	AbbVie Inc
06/02/2021	7:00AM	PR Newswire (US)	New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® (upadacitinib) in Patients with Rheumatoid Arthritis to be Pre...	NYSE:ABBV	AbbVie Inc
06/01/2021	5:02PM	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NYSE:ABBV	AbbVie Inc
05/26/2021	5:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/26/2021	8:15AM	PR Newswire (US)	AbbVie to Present at Bernstein's 37th Annual Strategic Decisions Conference	NYSE:ABBV	AbbVie Inc
05/26/2021	8:00AM	PR Newswire (US)	AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society (AHS) Annual Scientific Meet...	NYSE:ABBV	AbbVie Inc
05/25/2021	9:03AM	Dow Jones News	AbbVie Gets European Expanded Approval of Venclyxto	NYSE:ABBV	AbbVie Inc
05/25/2021	8:00AM	PR Newswire (US)	AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) in Combination with a Hypomethylating Agent for Pati...	NYSE:ABBV	AbbVie Inc
05/25/2021	8:00AM	PR Newswire (US)	AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheuma...	NYSE:ABBV	AbbVie Inc
05/24/2021	9:15AM	PR Newswire (US)	AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI®) Achieves Clinical Remission and Endoscopic ...	NYSE:ABBV	AbbVie Inc
05/24/2021	8:45AM	PR Newswire (US)	The Lancet Publishes Results from Pivotal Global Phase 3 Program Evaluating RINVOQ® (upadacitinib) in Atopic Dermatitis	NYSE:ABBV	AbbVie Inc
05/20/2021	8:00AM	PR Newswire (US)	AbbVie to Present at the UBS Global Healthcare Virtual Conference	NYSE:ABBV	AbbVie Inc
05/19/2021	8:00AM	PR Newswire (US)	AbbVie to Showcase Breadth of Oncology Portfolio and Pipeline at the 2021 ASCO and EHA Annual Congresses	NYSE:ABBV	AbbVie Inc
05/18/2021	4:10PM	Dow Jones News	House Committee Takes on Pricing, Patents for Top-Selling Drug Humira--Update	NYSE:ABBV	AbbVie Inc
05/18/2021	1:06PM	Dow Jones News	House Committee Takes on Pricing, Patents for Top-Selling Drug Humira	NYSE:ABBV	AbbVie Inc
05/18/2021	10:18AM	Dow Jones News	House Committee Takes on Pricing, Patents for Top-Selling Drug Humira	NYSE:ABBV	AbbVie Inc
05/12/2021	5:13PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NYSE:ABBV	AbbVie Inc
05/12/2021	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/12/2021	8:00AM	PR Newswire (US)	AbbVie to Present at the RBC Capital Markets Global Healthcare Conference	NYSE:ABBV	AbbVie Inc
05/11/2021	5:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc